PTX3 and age-related macular degeneration: Mean (±standard deviation) plasma PTX3 levels were 6.43±2.07 ng/ml for young controls, 6.37±2.49 ng/ml for aged controls, 5.93±2.07 ng/ml for patients with early AMD (CARMS grade 2–3), 6.45±1.96 ng/ml for patients with geographic atrophy (CARMS grade 4), and 5.70±2.50 ng/ml for patients with exudative AMD (CARMS grade 5).